Match Document Document Title
DE102018104590A1 Nutraceutical or pharmaceutical composition  
The present invention relates to a nutraceutical or pharmaceutical composition for use in improving endurance performance, and to a nutraceutical or pharmaceutical composition for use in...
DE102017007658A1 Veterinary composition and its use  
The problem with the available galenical compositions in the veterinary field is that they do not adequately transport active substances into inflammatory diseases and postoperative therapies into...
DE102017112543A1 Overtape for a transdermal delivery system  
The present invention relates to an overtape (10, 20) for a transdermal delivery system (TDS, 100, 200), wherein the overtape comprises a drug-free pressure-sensitive adhesive matrix (2) and a...
DE212016000236U1 Human endothelin receptor binding antibody and its use  
A specific antibody to human endothelin receptors, characterized in that the antibody comprises one of the following schemes of amino acid sequences: a. CDR3 sequence of a light chain selected...
DE112016002962T5 Family of ATP-binding cassette-encoding polyribonucleotides and formulations thereof  
Polynucleotides encoding peptides, proteins, enzymes and functional fragments thereof are disclosed. The polynucleotides of the disclosure can be efficiently delivered to an organ, such as the...
DE112005000725B4 Methods and compositions for treating ion imbalances  
A composition containing a sodium-binding polymer, said polymer having at least one polyvinyl sulfonate polymer, polyvinyl sulfamate polymer, polyvinyl sulfamate / vinyl sulfate copolymer, vinyl...
DE112015005869T5 Chinese medicinal composition for preventing or treating cardiovascular and cerebrovascular diseases or dementia, and preparation method and use thereof  
There are disclosed a Chinese medicinal composition for preventing or treating cardiovascular and cerebrovascular diseases and / or dementia, and a preparation method and use thereof. The...
DE102017204379A1 Preparation method of a water-soluble ginkobate extract and water-soluble ginkobate extract  
The present invention relates to the technical field of a preparation of traditional Chinese medicine, in particular to a preparation method of a water-soluble ginkoblate extract and a...
DE102016104470A1 A composition for promoting the activity of sirtuins  
The invention relates to a composition containing as active ingredient ectoine, hydroxyectoin and / or salts, esters or amides of these compounds for promoting the activity of sirtuins, in...
DE102016001672A1 A process for the preparation of a beverage  
A process for preparing a health-promoting beverage comprising the steps of: providing of the necessary natural plant raw materials (5) provide lemon and ginger, preferably pretreating the raw...
DE202017003762U1 Organic Aronia birch sap  
Aronia bark juice characterized in that the aronia bark juice consists of a mixture of aronia and birch juice.
DE102015220700A1 New chemical compounds, their preparation and their use  
The invention relates to novel chemical compounds, their preparation and their use in medicine, but also for catalysts or other materials. According to the invention, the compounds have the...
DE102015117882A1 Pharmaceutical composition  
The present invention relates to a pharmaceutical composition for the treatment and / or prophylaxis of obesity and / or an NADPH superoxide anion (O.2• -) -assisted cardiovascular disease.
DE102014202318B4 An improved process for the preparation of Ginkgo extracts  
A process for the preparation of a dry extract of Ginkgo biloba leaves with a content of 22.0 wt .-% to 27.0 wt .-% flavonoids, expressed as flavone glycosides, 2.6 wt .-% to 3.2 wt .-%...
DE212015000033U1 Therapeutic astaxanthin and phospholipid  
Dietary supplement composition formulated in an amount effective to promote the maintenance of cardiovascular health, including astaxanthin and a mixture of a phospholipidreichen roe extract and...
DE202016000774U1 Magnesium, potassium, alkaline reacting salts, lemon balm and B vitamins containing composition  
A magnesium, at least one alkaline-acting salt, lemon balm and B vitamins B1, B2, B3, B6 and B12-containing composition as a dietary supplement for stress and nutritional deficiencies of...
DE102014111892A1 Prophylaxis and treatment of infection by the hantavirus  
The present invention relates to an inhibitor for the prophylaxis and treatment of infection of a living being with a hantavirus and to a pharmaceutical composition containing the inhibitor.
DE102015104360A1 PHARMACEUTICAL COMPOSITION OF INHALATION TYPE FOR THE TREATMENT OF HEART DISEASE AND PREPARATION METHOD THEREOF  
The present invention provides a pharmaceutical composition inhaling type of heart disease, and a preparation method thereof prepared comprising a first gas and an atomized medication. The first...
DE102014004112A1 Pharmaceutical and Therapeutic Use of S - Acetylgluthation micronized 1 <100 microns and 1> 100 nm.  
The invention relates to the basis of the patent EP 0327 612 B1, By micronizing the particle size of the substance S-acetyl 1 <100 μ and 1 <100 nm, the bioavailability is significantly improved in...
DE102014201651A1 Isoxazole derivatives for use in the treatment and / or prophylaxis of heart disease  
The invention relates to isoxazole derivatives or pharmaceutically acceptable salts thereof for the treatment and / or prophylaxis of heart diseases. Such heart disease may be heart failure,...
DE102013015334A1 Magnesium-liposome complexes  
The present invention relates to magnesium-liposome complexes sustained release magnesium, which are at least partially coated with a polyalkylene glycol. Furthermore, the present invention...
DE112013002717T5 Induction of arteriogenesis with a NO (nitric oxide) donor  
The present invention relates inter alia to a method for promoting collateral circulation, including the step of exposure of an individual to a therapeutically effective amount of a NO-donor,...
DE69831673C5 USE OF EXEDINEN AND THEIR ANTAGONISTS TO REDUCE THE food intake  
Use of an exendin or an exendin agonist selected from exendin-3, exendin-4, exendin-4 (1-30), Exendin-4- (1-30) amide, exendin-4 (1-28) - amide, 14Leu, 25Phe exendin-4 amide, 14Leu, 25Phe...
DE202014005215U1 Complementary and by scientific studies indicated indications for SAG (S-acetylglutathione) and SAG mic (micronized SAG) in the range 1-100 nm and 1-40 μm for the pharmaceutical and therapeutic area  
Protection claims of SAG + SAG with micronized in the range of 1-40 microns and 1-100 nm, characterized in that it is used in the pharmaceutical and therapeutic 1 respiratory diseases 2 diabetes 3...
DE102013007979A1 Formulations for the treatment or prevention of proteinuria  
The present invention relates to the use of flavonoids, in particular rutin, or derivatives or precursors thereof, for the treatment of proteinuria, and to a process for the preparation of a...
DE102010060693B4 Use of the probiotic strain, GM-080 in the treatment of cardiac inflammation and apoptosis  
Composition for use in the treatment of cardiac inflammation, and heart cell apoptosis, the GM-080 a probiotic strain paracasei from Lactobacillus strain GM-080 (deposited with the China Center...
DE69331233C5 2-cycloalkyl or arylalkyl-DERIVATIVES OF NON-ACID, ZYKLOPENTANE-heptanoic ACID  
A pharmaceutical composition comprising cyclopentane N-ethyl heptene amide-5-cis-2-((3-αhydroxy-5-phenyl-1-trans-pentenyl)-3,5 dihydroxy, [1a2b3a, 5a].
DE112012003484T5 Tribulus terrestris, Avena sativa and Panax ginseng extract combination  
The present invention relates to a vegetable (herbales) pharmaceutical product which has been obtained from defined parts of Tribulus terrestris, Avena sativa and Panax ginseng plants, for use as...
DE102012020542A1 Use of an active ingredient consisting of e.g. tocotrienols in the substantial absence of tocopherols, for the prevention or treatment of e.g. normal or pathological inflammatory diseases, pain, diseases of nervous system, and cancer  
Use of an active ingredient consisting of tocotrienols in the substantial absence of tocopherols, derivatives of tocotrienols in the substantial absence of tocopherols, tocotrienols enriched with...
DE202013010193U1 A composition for use in an inhalation device and usable for this inhalation device  
A composition for use in the prophylactic and / or therapeutic treatment of diseases wherein the composition comprises at least two different essential oils, in particular at least three distinct...
DE59209330C5 Benzimidazoles, medicaments containing these compounds and processes for their preparation  
Benzimidazoles of the general formula in the R1 a chlorine atom, an alkyl group having 1 to 3 carbon atoms or a trifluoromethyl group, R2 a 5-, 6- or 7-membered Alkyleniminogruppe in which a...
DE112011102356T5 A pharmaceutical combination composition and methods for treating diseases or conditions associated with the cardiovascular system  
The present application provides a pharmaceutical composition for administration to a patient who suffers from at least one symptom of a cardiovascular condition, said composition comprising a) an...
DE102011018586A1 New vector system, useful e.g. as a part of a viral or non-viral gene transfer vector to control targeted expression of a therapeutic DNA sequence and as a part of transfer construct or gene construct for modifying embryonic stem cells  
Vector system is new, where the vector system is a part of a viral or non-viral gene transfer vector, in which a desired gene, a complementary DNA (cDNA) or a functional DNA segment linked to the...
DE102011007891A1 New ring-fused 4-aminopyrimidine compounds are guanylate cyclase stimulators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease and renal insufficiency  
Ring-fused 4-aminopyrimidine compounds (I) and their N-oxides, salts, solvates, salts of N-oxides or solvates of N-oxides and salts, are new. Ring-fused 4-aminopyrimidine compounds of formula (I)...
DE102011007890A1 New fluoroalkyl-substituted pyrazolopyridine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency  
Fluoroalkyl-substituted pyrazolopyridine compounds (I) are new. Fluoroalkyl-substituted pyrazolopyridine compounds of formula (I) and their N-oxides, salts, solvates, salts of N-oxides and...
DE102011016875A1 Preparation containing DISC1 and / or at least one DISC1 fragment for use in the therapeutic treatment of the human or animal body  
Preparation containing DISC1 and / or at least one DISC1 fragment for use in the therapeutic treatment of the human or animal body, preferably in addition at least one immunostimulatory substance...
DE102011007272A1 Branched 3-phenylpropionic acid derivatives and their use  
The present application relates to novel, a branched or cyclic alkyl substituents bearing in the 3-position 3-phenylpropionic acid derivatives, processes for their preparation, their use for the...
DE102011006974A1 New substituted 1-benzylcycloalkylcarboxylic acid compounds are soluble guanylate cyclase activators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertension, ischemia and vascular disease  
Substituted 1-benzylcycloalkylcarboxylic acid compounds (I) are new. Substituted 1-benzylcycloalkylcarboxylic acid compounds of formula (I) and their salts, solvates or solvates of the salts, are...
DE102011015142A1 Agent for the prophylaxis and treatment of age-related diseases and disorders, as well as extending the service life  
The present invention relates to an agent for the prophylaxis and / or treatment of an age-related disease and / or disorder as well as to increase the lifetime of a living being so that extension...
DE102011003315A1 New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful for treating and/or preventing e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease, and fibrotic disorder  
1H-Pyrazolo[3,4-b]pyridine compounds (I) or their N-oxides, salts, solvate, salts of N-oxide and solvates of N-oxides and salts, are new. 1H-Pyrazolo[3,4-b]pyridine compounds of formula (I) or...
DE102011000207A1 N-Arylaminomethylenbenzothiophenone as drugs  
The invention relates to N-Arylaminomethylenbenzothiophenone the general formula (I) for use as medicaments for the treatment of cardiovascular diseases, as well as a process for its synthesis.
DE102011008070A1 Use of tocotrienol for prevention, aftercare, treatment or auxiliary treatment of proliferative diseases, inflammatory diseases, heart disease, diseases of nervous system, and aftercare of surgical interventions or mitigation of swelling  
Use of tocotrienol for prevention, aftercare, treatment or auxiliary treatment of proliferative diseases, inflammatory diseases, heart/circulatory disease, diseases of the nervous system, and...
DE102010062544A1 New substituted 1-benzylcycloalkylcarboxylic acid compounds are soluble guanylate cyclase activators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertension, pulmonary hypertension and vascular disease  
Substituted 1-benzylcycloalkylcarboxylic acid compounds (I) and their salts, solvates or solvates of the salts, are new. Substituted 1-benzylcycloalkylcarboxylic acid compounds of formula (I) and...
DE102005023301B4 A pharmaceutical composition comprising progestins and / or estrogens and 5-methyl- (6S) -tetrahydrofolate  
medicaments containing - 5-methyl- (6S) tetrahydrofolate, - One or more estrogens and / or progestogens, - And pharmaceutically acceptable auxiliaries / carriers in the absence of vitamin B12,
DE102010052941A1 Therapeutic protein  
The present invention relates to the use of the protein Gremlin, and a fusion protein comprising a) a first poly-peptide having an immunoglobulin Fc domain, as well as b), comprises a second...
DE102010044131A1 Substituted sodium-1H-pyrazol-5-olate  
The present application relates to sodium-1- [6- (morpholin-4-yl) pyrimidin-4-yl] -4- (1H-1,2,3-triazol-1-yl) -1H-pyrazol-5-olate , process for its preparation, its use for the treatment and / or...
DE102010048800A1 quinoxaline  
Compounds of formula I wherein R, R1 and R2 have the meanings given in claim 1, are PI3K inhibitors and can, inter alia, for the treatment of autoimmune disease, inflammation, cardiovascular...
DE102010043380A1 Benzyl-substituted carbamates and their use  
The present application relates to novel benzyl-substituted carbamates, a process for their preparation, their use alone or in combinations for the treatment and / or prophylaxis of diseases and...
DE102010043379A1 Substituted 6-fluoro-1H-pyrazolo [4,3-b] pyridines and their use  
The present application relates to novel substutuierte 6-fluoro-1H-pyrazolo [4,3-b] pyridines, to processes for their preparation, their use alone or in combinations for the treatment and / or...
DE102010043318A1 Calcium-containing composition  
The invention relates to the use of an oral solid dosage form for the prevention or treatment of lifestyle diseases such as cardiovascular disease, cancer, hypertension, diabetes, osteoporosis,...